Mar 20, 2018 12:30 pm UTC| Business
IRVINE, Calif., March 20, 2018 -- Corix Bioscience Inc. (OTCQB: CXBS), an emerging developer of proprietary cannabis and industrial hemp strains earmarked specifically for use in important healthcare applications, today...
Grown Rogue Introduces CO2 Cartridges, Featuring a Full Spectrum of Cannabinoids and Terpenes
Mar 20, 2018 12:30 pm UTC| Business
Medford, Oregon , March 20, 2018 -- As a pioneer in developing cannabis products that provide consistent experiences to consumers, Grown Rogue is now making “The Right Experience” products available in CO2 oil cartridge...
Progenics Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
Mar 20, 2018 12:30 pm UTC| Business
NEW YORK, March 20, 2018 -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, announced today that Mark...
Plandai Biotechnology Issues Business Targets and Milestones for Remainder of 2018
Mar 20, 2018 12:30 pm UTC| Business
Looking to Ramp Commercialization and Accelerate Revenue Growth LONDON, UNITED KINGDOM, March 20, 2018 -- Plandaí Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandaí”), a producer of nutraceutical and...
SANUWAVE Announces a New "SHOCK THIS" Blog
Mar 20, 2018 12:30 pm UTC| Business
SUWANEE, GA, March 20, 2018 -- SANUWAVE Health, Inc. (OTCQB: SNWV) announces another installment of their blog, SHOCK THIS on its website, www.sanuwave.com. As with the previous blogs, this seventh installment...
First Commercial Finance Portfolio Exceeds $1Billion
Mar 20, 2018 12:30 pm UTC| Business
INDIANAPOLIS, March 20, 2018 -- Rick Dennen, President of First Commercial Finance, the national commercial lending platform that operates under the Oak Street Funding® and First Franchise Capital™ brands, announced...
Physeon GmbH to Attend RESI Investor Conference in Toronto, Canada on April 10, 2018
Mar 20, 2018 12:30 pm UTC| Business
SCHAFFHAUSEN, Switzerland, March 20, 2018 -- Physeon® GmbH, (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today announced that the Company will attend the RESI...